Electromed, Inc. Stock

Equities

ELMD

US2854091087

Advanced Medical Equipment & Technology

Delayed Nyse 03:10:57 2024-04-25 pm EDT 5-day change 1st Jan Change
16.09 USD -3.83% Intraday chart for Electromed, Inc. +15.42% +47.48%
Sales 2024 * 54.7M Sales 2025 * - Capitalization 144M
Net income 2024 * 4M Net income 2025 * - EV / Sales 2024 * 2.63 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * -
P/E ratio 2024 *
35.6 x
P/E ratio 2025 *
-
Employees 170
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.3%
More Fundamentals * Assessed data
Dynamic Chart
1 day+2.07%
1 week+18.40%
Current month+3.59%
1 month-2.90%
3 months+65.15%
6 months+62.43%
Current year+53.35%
More quotes
1 week
14.00
Extreme 14
16.73
1 month
13.90
Extreme 13.9
16.78
Current year
9.81
Extreme 9.81
17.85
1 year
8.80
Extreme 8.8
17.85
3 years
8.75
Extreme 8.75
17.85
5 years
4.75
Extreme 4.75
19.73
10 years
1.00
Extreme 1
19.73
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 23-06-30
Director of Finance/CFO 42 22-11-13
Chairman 68 12-11-30
Members of the board TitleAgeSince
Chairman 68 12-11-30
Director/Board Member 55 19-08-14
Director/Board Member 60 21-11-11
More insiders
Date Price Change Volume
24-04-25 16.09 -3.83% 18 357
24-04-24 16.73 +2.07% 20,645
24-04-23 16.39 +4.26% 66,097
24-04-22 15.72 +8.41% 48,986
24-04-19 14.5 +4.02% 22,289

Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT

More quotes
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. The Company applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. Its SmartVest Connect wireless technology is a personalized HFCWO therapy management portal for patients with compromised pulmonary function. The SmartVest Connect app securely connects to the SmartVest System through Bluetooth technology. The Company also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
16.73 USD
Average target price
26 USD
Spread / Average Target
+55.41%
Consensus